Skip to content
OpenCapital
Get started

Agilon Health AGL AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value at other companies

CVS Health logo
CVS HealthCVS
——

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's afs and trading securities - unrealized loss position (<12 months) fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's AFS and trading securities - unrealized loss position (<12 months) fair value?
Agilon Health (AGL) reported AFS and trading securities - unrealized loss position (<12 months) fair value of $12.93M in Q4 2025.
How has Agilon Health's AFS and trading securities - unrealized loss position (<12 months) fair value changed year-over-year?
Agilon Health's AFS and trading securities - unrealized loss position (<12 months) fair value decreased by 48.9% year-over-year, from $25.3M to $12.93M.
What is the long-term trend for Agilon Health's AFS and trading securities - unrealized loss position (<12 months) fair value?
Over 3 years (2022 to 2025), Agilon Health's AFS and trading securities - unrealized loss position (<12 months) fair value has grown at a -68.3% compound annual growth rate (CAGR), from $407.4M to $12.93M.